1.05 USD
↗ 0.01 (0.97%)LIVE (AS OF 03:21 PM EDT)
Pliant Therapeutics, Inc. Common Stock
PLRXNASDAQ • USD
Market: OPEN
Pliant Therapeutics, Inc. Common Stock (PLRX) trades at $1.05 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 2, 2026.
Open?$1.04
High?$1.09
Low?$1.03
Prev. Close?$1.04
Volume?253.9K
Avg. Volume?370.0K
VWAP?$1.03
Rel. Volume?0.69x
Bid / Ask
Bid?$1.03 × 1.0K
Ask?$1.04 × 800
Spread?$0.01
Midpoint?$1.04
Valuation & Ratios
Market Cap?64.4M
Shares Out?61.9M
Float?48.2M
Float %?77.8%
P/E Ratio?N/A
P/B Ratio?0.44
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Employees
49
Market Cap
64.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-03
Address
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.52Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?7.67%Elevated
Short Interest?3.7M
Days to Cover?8.9
Free Float48.2M
Avg Daily Volume416.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?9.90Strong
Quick Ratio?9.90Strong
Cash Ratio?1.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.44CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-62.8%WEAK▾
S&P3
ROA?-48.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-70895000
Enterprise Value?$39.5M
Fundamentals ratios updated end of day